Thursday, 11. April 2024

Perioperative and palliative systemic treatments for biliary tract cancer

PHPSESSID: Technisch notwendiges Cookie vom Webserver. Ablauf: Session. Typ: HTTP
fcc_cookie_consent: Notwendig zur Zustimmungseinholung zu bestimmten Cookies und somit zum Einsatz bestimmter Tools. Ablauf: 1 Jahr. Typ: HTTP
klpw_necessary: Steuerung der Cookie-Zustimmung. Ablauf: 1 Jahr. Typ: HTTP
klpw_analysis_matomo: Wird verwendet, um zu überprüfen, ob der Benutzer Matomo-Cookies zulässt. Ablauf: 1 Jahr. Typ: HTTP
klpw_functional_youtube: Wird verwendet, um zu überprüfen, ob der Benutzer YouTube-Cookies zulässt. Ablauf: 1 Jahr. Typ: HTTP

Recent publication

Dr Hossein Taghizadeh MSc PhD from the Division of Internal Medicine 1 at the University Hospital St Pölten and colleagues from other universities have published a review on the treatment of biliary tract cancer in the journal "Therapeutic Advances in Medical Oncology". The researchers discuss the use of neoadjuvant therapy, palliative systemic therapy approaches and novel treatment concepts that are already being used in selected cases. These have the potential to improve patient outcomes in the future. Biliary tract cancer is currently the cancer with the worst prognosis.

Taghizadeh, H, Dong, Y, Gruenberger, T & Prager, GW 2024, 'Perioperative and palliative systemic treatments for biliary tract cancer', Therapeutic Advances in Medical Oncology, vol. 16, pp. 17588359241230756. https://doi.org/10.1177/17588359241230756

See publication at the KL Research information system KRIS